FABRY DISEASE - ClinicalTrials.gov

A French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat - the MIGA-FAB Study

This will include retrospective data collection up to the migalastat launch date and a prospective follow-up from 1 to 3. 5 years in migalastat-treated patients with Fabry disease who have a GLA mutation amenable to migalastat. A Fabry disease patient's clinical decision is used to describe a diagnostic and customary clinical care regiment/practice process that a clinician chooses according to their clinical decision.

Source link: https://clinicaltrials.gov/ct2/show/NCT04602364

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions